COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 3, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Intranasal Insulin Could Help Slow Age-related Cognitive Decline, Suggests a New Study
Treatment with intranasal insulin improved executive function and verbal memory, as well as other measures, in participants with and without type 2 diabetes.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 2, 2022
Study: Investigational RSV Vaccine Elicited Neutralizing Antibody Responses in Pregnant Women
Results from a phase 2b trial showed that a bivalent RSV prefusion F protein-based vaccine was safe and led to higher neutralizing antibody responses in pregnant women.
FDA Approves Mavacamten, First-in-Class Treatment for Obstructive Hypertrophic Cardiomyopathy
The cardiac myosin inhibitor is the only treatment that targets the pathophysiology of the disease, improving patient function and symptoms.
Detox, Withdrawal, Rehab, Relapse: The Experience of Heavy Drinkers
Approximately one-third of survey respondents with AUD relapsed within 1 year of stopping. Find a profile here of the experience of recovery from those who are trying.
Novel Once-Weekly Insulin Icodec Found Superior vs Insulin Degludec in Reducing HbA1c in Type 2 Diabetes
The ONWARDS 2 trial achieved its primary endpoint of demonstrating non-inferiority in reducing HbA1c at week 26 with insulin icodec vs insulin degludec.
Adults with Asthma Found at Higher Risk for Obesity in International Study
The observational study found that longer duration of disease conferred a 32% greater risk of obesity and that nonatopic asthma carried at 47% greater risk.
Talking Cannabis & Brain Health: Why One Expert Says Not to Condemn Use
When talking to younger cannabis users, Henry Mahncke, PhD, says it is important to first understand the underlying causes of use before counseling against it.
Remdesivir Wins FDA Approval for Treatment of COVID-19 in Youngest Patients
The US FDA expanded approval of remdesivir this week to include pediatric patients aged 28 days and older, the first COVID-19 treatment indicated for this population.
Tirzepatide Yields Top Weight Loss of 20% or More in SURMOUNT Clinical Trial
Tirzepatide was associated with reductions in body weight of up to 22.5% over 72 weeks in the global phase 3 registration trial.
Moderna Announces Filing for Emergency Use Authorization for its COVID-19 Vaccine in Children Under Age 6 Years
The biotechnology company said on Thursday that similar requests are underway with international regulatory authorities.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 27, 2022
Study: State Laws Intended to Reduce Opioid Prescribing had Little Impact on Prescribing Practices
Study addresses the concern that state opioid prescription laws may lead to some chronic pain patients missing out on critical pain treatment.
White House Announces Plan to Increase COVID-19 Antiviral Availability, Build Provider, Patient Awareness
As many as 40 000 pharmacies will soon have supplies of Paxlovid while the administration ramps up communications to clinicians and patients on access and use.
USPSTF Finalizes Recommendations for Use of Aspirin in Primary CVD Prevention
USPSTF states low-dose aspirin should be considered for CVD prevention on a case-by-case basis in adults aged 40-59 yrs with a 10% or greater 10-year CVD risk.
Heavy Drinkers Report Impact of Alcohol Use: The Recovery Village Survey Highlights
More than one-third of survey respondents began drinking before age 15; the heaviest drinkers had double the risk for cirrhosis, CVD, pancreatitis, and neuropathy.
Seen in the ED: Wrist Injury Imaging
A skateboarding accident brings a man in his 30s to the ED complaining of wrist pain. Can you make the diagnosis based on the x-ray?
Pulmonary Rehab Improves Lung Function, QOL in Asthma-COPD Overlap Plus Obesity
Asthma-COPD overlap and obesity mutually exacerbate each other and an early program of pulmonary rehabilitation shows promise to help both.
SuperWIN Retail Nutrition Counseling Study Coauthor Unpacks Findings that Surprised Him
Dylan Steen, MD talks about several SuperWIN results that caught him happily by surprise and suggest plenty of room for follow-up research.